162 related articles for article (PubMed ID: 37927190)
1. Does switching from coated colchicine to compressed colchicine improves treatment response in patients with familial Mediterranean fever?
Öner N; Çelikel E; Tekin ZE; Güngörer V; Kurt T; Sezer M; Tekgöz N; Karagöl C; Coşkun S; Kaplan MM; Polat MC; Acar BÇ
Croat Med J; 2023 Oct; 64(5):354-361. PubMed ID: 37927190
[TBL] [Abstract][Full Text] [Related]
2. Is compressed colchicine tablet superior to other colchicine preparations in patients with familial Mediterranean fever?
Vasi İ; Kardaş RC; Yıldırım D; Kaya B; Duran R; Karadeniz H; Avanoğlu Güler A; Erden A; Küçük H; Göker B; Tufan A; Öztürk MA
Int J Clin Pharmacol Ther; 2024 Feb; 62(2):77-82. PubMed ID: 37969097
[TBL] [Abstract][Full Text] [Related]
3. Do all colchicine preparations have the same effectiveness in patients with familial Mediterranean fever?
Baglan E; Ozdel S; Bulbul M
Mod Rheumatol; 2021 Mar; 31(2):481-484. PubMed ID: 32613873
[TBL] [Abstract][Full Text] [Related]
4. Different pharmaceutical preparations of colchicine for Familial Mediterranean Fever: are they the same?
Emmungil H; İlgen U; Turan S; Yaman S; Küçükşahin O
Rheumatol Int; 2020 Jan; 40(1):129-135. PubMed ID: 31463607
[TBL] [Abstract][Full Text] [Related]
5. Effect of anti-interleukin-1 treatment on quality of life in children with colchicine-resistant familial Mediterranean fever: A single-center experience.
Kurt T; Aydın F; Nilüfer Tekgöz P; Sezer M; Uncu N; Çelikel Acar B
Int J Rheum Dis; 2020 Jul; 23(7):977-981. PubMed ID: 32558310
[TBL] [Abstract][Full Text] [Related]
6. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
Eroglu FK; Beşbaş N; Topaloglu R; Ozen S
Rheumatol Int; 2015 Oct; 35(10):1733-7. PubMed ID: 26001859
[TBL] [Abstract][Full Text] [Related]
7. A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever.
Corsia A; Georgin-Lavialle S; Hentgen V; Hachulla E; Grateau G; Faye A; Quartier P; Rossi-Semerano L; Koné-Paut I
Orphanet J Rare Dis; 2017 Mar; 12(1):54. PubMed ID: 28302131
[TBL] [Abstract][Full Text] [Related]
8. Anti-interleukin-1 treatment in 26 patients with refractory familial mediterranean fever.
Kucuksahin O; Yildizgoren MT; Ilgen U; Ates A; Kinikli G; Turgay M; Erten S
Mod Rheumatol; 2017 Mar; 27(2):350-355. PubMed ID: 27328763
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis.
Varan Ö; Kucuk H; Babaoglu H; Guven SC; Ozturk MA; Haznedaroglu S; Goker B; Tufan A
Mod Rheumatol; 2019 Mar; 29(2):363-366. PubMed ID: 29578360
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of intravenous Colchicine in children with Familial Mediterranean Fever.
Tal R; Semo Oz R; Amarilyo G; Eidlitz-Marcus T; Goldberg O; Levinsky Y; Peled O; Harel L
Rheumatol Int; 2020 Jan; 40(1):121-128. PubMed ID: 31230112
[TBL] [Abstract][Full Text] [Related]
11. Interventions for reducing inflammation in familial Mediterranean fever.
Yin X; Tian F; Wu B; Xu T
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD010893. PubMed ID: 35349164
[TBL] [Abstract][Full Text] [Related]
12. Familial Mediterranean fever-associated infertility and underlying factors.
Atas N; Armagan B; Bodakci E; Satis H; Sari A; Bilge NSY; Salman RB; Yardımcı GK; Babaoglu H; Kilic L; Ozturk MA; Goker B; Haznedaroglu S; Kasifoglu T; Kalyoncu U; Tufan A
Clin Rheumatol; 2020 Jan; 39(1):255-261. PubMed ID: 31502094
[TBL] [Abstract][Full Text] [Related]
13. Update on the management of colchicine resistant Familial Mediterranean Fever (FMF).
El Hasbani G; Jawad A; Uthman I
Orphanet J Rare Dis; 2019 Oct; 14(1):224. PubMed ID: 31615541
[TBL] [Abstract][Full Text] [Related]
14. Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis.
Özçakar ZB; Özdel S; Yılmaz S; Kurt-Şükür ED; Ekim M; Yalçınkaya F
Clin Rheumatol; 2016 Feb; 35(2):441-6. PubMed ID: 25213327
[TBL] [Abstract][Full Text] [Related]
15. Successful management of colchicine resistant familial Mediterranean fever patients with a standardized canakinumab treatment protocol: a case series and literature review.
Eren Akarcan S; Dogantan S; Edeer Karaca N; Aksu G; Kutukculer N
Rheumatol Int; 2020 Jan; 40(1):161-168. PubMed ID: 31273456
[TBL] [Abstract][Full Text] [Related]
16. Anti-interleukin-1 treatment among patients with familial Mediterranean fever resistant to colchicine treatment. Retrospective analysis.
Sargin G; Kose R; Senturk T
Sao Paulo Med J; 2019 May; 137(1):39-44. PubMed ID: 31116269
[TBL] [Abstract][Full Text] [Related]
17. Biological agents in familial Mediterranean fever focusing on colchicine resistance and amyloidosis.
Sozeri B; Kasapcopur O
Curr Med Chem; 2015; 22(16):1986-91. PubMed ID: 25760087
[TBL] [Abstract][Full Text] [Related]
18. Colchicine-intolerant familial mediterranean fever patients: A comparative study between different colchicine doses and IL-1 inhibitor monotherapy.
Yildirim D; Kardas RC; Gun M; Kaya B; Vasi I; Duran R; Karadeniz H; Avanoglu Guler A; Kucuk H; Erden A; Goker B; Ozturk MA; Tufan A
Int Immunopharmacol; 2024 Feb; 128():111491. PubMed ID: 38241844
[TBL] [Abstract][Full Text] [Related]
19. The remarkable characteristics of the children with colchicine-resistant familial Mediterranean fever in Turkey.
Sahin N; Ozdemir Cicek S; Pac Kisaarslan A; Poyrazoglu MH; Gunduz Z; Dusunsel R
Mod Rheumatol; 2022 Jan; 32(1):177-185. PubMed ID: 33775204
[TBL] [Abstract][Full Text] [Related]
20. Is the performance of the international severity scoring system for familial mediterranean fever in children better than other scoring systems?
Ozcan G; Cayci S; Celikel Acar B; Basaran O; Aydin F; Elhan AH; Cakar N
Int J Clin Pract; 2021 Nov; 75(11):e14678. PubMed ID: 34328662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
